Genome Therapy of Myotonic Dystrophy Type 1 i
- Slides: 8
Genome Therapy of Myotonic Dystrophy Type 1 i. PS Cells for Development of Autologous Stem Cell Therapy Yuanzheng Gao, Xiuming Guo, Katherine Santostefano, Yanlin Wang, Tammy Reid, Desmond Zeng, Naohiro Terada, Tetsuo Ashizawa, Guangbin Xia Molecular Therapy Volume 24 Issue 8 Pages 1378 -1387 (August 2016) DOI: 10. 1038/mt. 2016. 97 Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
Figure 1 Molecular Therapy 2016 241378 -1387 DOI: (10. 1038/mt. 2016. 97) Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
Figure 2 Molecular Therapy 2016 241378 -1387 DOI: (10. 1038/mt. 2016. 97) Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
Figure 3 Molecular Therapy 2016 241378 -1387 DOI: (10. 1038/mt. 2016. 97) Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
Figure 4 Molecular Therapy 2016 241378 -1387 DOI: (10. 1038/mt. 2016. 97) Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
Figure 5 Molecular Therapy 2016 241378 -1387 DOI: (10. 1038/mt. 2016. 97) Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
Figure 6 Molecular Therapy 2016 241378 -1387 DOI: (10. 1038/mt. 2016. 97) Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
Figure 7 Molecular Therapy 2016 241378 -1387 DOI: (10. 1038/mt. 2016. 97) Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
